Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Non-Current Debt (2018 - 2025)

Historic Non-Current Debt for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to $151.5 million.

  • Health Catalyst's Non-Current Debt rose 3219.67% to $151.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $151.5 million, marking a year-over-year increase of 3219.67%. This contributed to the annual value of $151.2 million for FY2024, which is 3370.37% down from last year.
  • As of Q3 2025, Health Catalyst's Non-Current Debt stood at $151.5 million, which was up 3219.67% from $151.4 million recorded in Q2 2025.
  • Health Catalyst's 5-year Non-Current Debt high stood at $228.8 million for Q2 2024, and its period low was $114.6 million during Q3 2024.
  • In the last 5 years, Health Catalyst's Non-Current Debt had a median value of $225.4 million in 2022 and averaged $194.5 million.
  • Its Non-Current Debt has fluctuated over the past 5 years, first soared by 25446.84% in 2021, then plummeted by 4965.58% in 2024.
  • Health Catalyst's Non-Current Debt (Quarter) stood at $180.9 million in 2021, then rose by 25.19% to $226.5 million in 2022, then rose by 0.67% to $228.0 million in 2023, then crashed by 33.7% to $151.2 million in 2024, then rose by 0.22% to $151.5 million in 2025.
  • Its last three reported values are $151.5 million in Q3 2025, $151.4 million for Q2 2025, and $151.3 million during Q1 2025.